Lenacapavir: A Game-Changer in H.I.V. Prevention Approved by Regulators in 2023

This groundbreaking medication has the potential to significantly alter the trajectory of the AIDS epidemic. However, under the Trump administration, funding initiatives that could have supported its distribution in low-income nations have been severely reduced. As we approach 2025, the impact of these policy changes on global health could prove detrimental to efforts aimed at combating this persistent crisis.